• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Berberine Improves Cognitive Function and Hippocampal Insulin Sensitivity in Diabetic Mice

by
November 14, 2026
in Biology
Reading Time: 2 mins read
0
Berberine Improves Cognitive Function and Hippocampal Insulin Sensitivity in Diabetic Mice

Berberine Improves Cognitive Function and Hippocampal Insulin Sensitivity in Diabetic Mice

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

The animal investigation demonstrated that berberine administration substantially decreased the formation of 4-hydroxy 2-nonenal (4-HNE) adducts while elevating levels of both insulin and insulin receptors in the hippocampus, indicating improved insulin uptake and signaling within the brain tissue of the treated diabetic rodents.

Berberine, a component of the Chinese herb, is used for treating diabetes and diabetes-associated cognitive dysfunction, although the underlying mechanism is still unclear.

To determine whether berberine could improve diabetes-associated cognitive dysfunction and to clarify the molecular pathways responsible for its actions, the research team conducted a controlled laboratory investigation using a mouse model. The researchers used streptozotocin to induce diabetes in mice. Berberine was administered to the animals both prior to and following the streptozotocin exposure for an overall intervention period of four weeks. The authors analyzed the impact of berberine on 4-hydroxy 2-nonenal adduct formation in diabetic mice and assessed the insulin signaling pathway to uncover the underlying molecular mechanism.

The molecular evaluations revealed that berberine treatment exerted pronounced positive effects on hippocampal insulin signaling pathways in the diabetic mice. Alongside the observed elevations in hippocampal insulin and insulin receptor concentrations, berberine therapy significantly increased the messenger RNA levels of key upstream and downstream signaling mediators, including phosphoinositide 3-kinase (PI3K), protein kinase B (AKT), mammalian target of rapamycin (mTOR), and S6 kinase. The upregulation of these critical pathway components indicates that berberine stimulates the PI3K/AKT/mTOR signaling cascade, thereby helping to improve hippocampal insulin resistance in diabetic mice.

Quantitative analysis revealed that berberine treatment decreased BAD and NF-κB mRNA levels in the hippocampus of diabetic mice. Furthermore, berberine treatment decreased tau hyperphosphorylation in the hippocampus of diabetic mice.

The research team also observed that berberine treatment increased the messenger RNA levels of the cyclic AMP response element-binding protein (CREB) and CREB-binding protein (CBP) in the hippocampus of the diabetic mice, supporting a neuro-regenerative role for the intervention. The study authors concluded that berberine effectively improves hippocampal insulin resistance by activating the PI3K/AKT/mTOR pathway, curbing 4-HNE adduct formation, and decreasing tau hyperphosphorylation in diabetic mice. The authors stated that their study highlights a novel therapeutic target in diabetes-associated cognitive dysfunction and a new mechanism of action of berberine.

Subject of Research: Berberine and cognitive dysfunction in diabetic mice

Article Title: Berberine improves cognitive impairment in diabetic mice by mitigating 4-HNE-induced oxidative stress and enhancing hippocampal insulin sensitivity

Article References: Gupta, M., Rumman, M., Mahdi, A. A., & Pandey, S. (2026). Berberine improves cognitive impairment in diabetic mice by mitigating 4-HNE-induced oxidative stress and enhancing hippocampal insulin sensitivity. Molecular Biology Reports, 53(1), Article 1865. https://doi.org/10.1007/s11033-026-13042-9

Image Credits: AI Generated

DOI: 10.1007/s11033-026-13042-9

Keywords: berberine, diabetes, cognitive dysfunction, diabetic mice, hippocampus, insulin receptors, streptozotocin, 4-hydroxy 2-nonenal, PI3K, AKT, mTOR, S6 kinase, tau hyperphosphorylation, NF-κB, BAD, CREB, CBP, insulin resistance

News Source: Drew Townsend. (November 14, 2026). Berberine Improves Cognitive Function and Hippocampal Insulin Sensitivity in Diabetic Mice. Scienmag.

Tags: 4-hydroxy-2-nonenalAKTBADberberineCBPcognitive dysfunctionCREBDiabetesdiabetic miceHippocampusinsulin receptorsinsulin resistancemTORNF-κBPI3KS6 kinasestreptozotocintau hyperphosphorylation
Share12Tweet7Share2ShareShareShare1

Related Posts

Engineered E. coli Secretes Thermophilic Cellulase Cocktail for Seawater-Compatible Biorefining

Engineered E. coli Secretes Thermophilic Cellulase Cocktail for Seawater-Compatible Biorefining

November 17, 2026
Pregnancy Significantly Alters Pharmacokinetics of Anti-Inflammatory Drug Flunixin in Goats

Pregnancy Significantly Alters Pharmacokinetics of Anti-Inflammatory Drug Flunixin in Goats

November 17, 2026

Experiential Workshop Expands Mexican Students’ Understanding of Bat Diets and Ecological Roles

November 17, 2026

Engineered Escherichia Coli Produces C14-Enriched Lipid Adjuvant Homologs in Bioreactor Batches

November 17, 2026

POPULAR NEWS

  • Structured IDEA Expert Elicitation Framework Enhances Design of Rare Disease Trials

    Structured IDEA Expert Elicitation Framework Enhances Design of Rare Disease Trials

    29 shares
    Share 12 Tweet 7
  • Syndesmotic Fixation Speeds Early Ankle Recovery but Matches Non-Fixation at Two Years

    29 shares
    Share 12 Tweet 7
  • German Nationwide Survey Identifies Workplace Bullying Patterns Across Industries and Age Groups

    29 shares
    Share 12 Tweet 7
  • TCAD Simulations Identify Efficiency Gains for Sustainable CZTS Solar Cells

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Structured IDEA Expert Elicitation Framework Enhances Design of Rare Disease Trials

Syndesmotic Fixation Speeds Early Ankle Recovery but Matches Non-Fixation at Two Years

German Nationwide Survey Identifies Workplace Bullying Patterns Across Industries and Age Groups

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.